All of these obesity-associated circulating factors are able to activate the PI3K/Akt and/or MAPK pathways, potentially enhancing the ERα crosstalk pathways described above and leading to endocrine resistance and breast cancer progression [24-28]. This evidence concerns the gene AKT1 and obesity disorder.